These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24124065)

  • 1. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.
    Meyer MR; Du P; Schuster F; Maurer HH
    J Mass Spectrom; 2010 Dec; 45(12):1426-42. PubMed ID: 21053377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry.
    Peters FT; Meyer MR; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):81-91. PubMed ID: 16046201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS.
    Meyer MR; Prosser D; Maurer HH
    Drug Test Anal; 2013 Apr; 5(4):259-65. PubMed ID: 23303532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GC-MS and LC-(high-resolution)-MS(n) studies on the metabolic fate and detectability of camfetamine in rat urine.
    Welter J; Kavanagh P; Maurer HH
    Anal Bioanal Chem; 2014 Jun; 406(16):3815-29. PubMed ID: 24828975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.
    Welter J; Meyer MR; Wolf EU; Weinmann W; Kavanagh P; Maurer HH
    Anal Bioanal Chem; 2013 Apr; 405(10):3125-35. PubMed ID: 23361230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the metabolism and detectability of the emerging drug of abuse diphenyl-2-pyrrolidinemethanol (D2PM) in rat urine using GC-MS and LC-HR-MS/MS.
    Meyer MR; Schmitt S; Maurer HH
    J Mass Spectrom; 2013 Feb; 48(2):243-9. PubMed ID: 23378097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
    Sauer C; Peters FT; Haas C; Meyer MR; Fritschi G; Maurer HH
    J Mass Spectrom; 2009 Jun; 44(6):952-64. PubMed ID: 19241365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.
    Meyer MR; Vollmar C; Schwaninger AE; Wolf E; Maurer HH
    J Mass Spectrom; 2012 Feb; 47(2):253-62. PubMed ID: 22359337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations using GC-MS, LC-MS(n), and LC-high resolution-MS/MS.
    Wink CS; Meyer GM; Zapp J; Maurer HH
    Anal Bioanal Chem; 2015 Feb; 407(6):1545-57. PubMed ID: 25577353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
    Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
    J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS/MS techniques and of its detectability by GC-MS or LC-MS(n) standard screening approaches.
    Helfer AG; Turcant A; Boels D; Ferec S; Lelièvre B; Welter J; Meyer MR; Maurer HH
    Drug Test Anal; 2015 May; 7(5):368-75. PubMed ID: 24953431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation and detectability of the designer drug 2,5-dimethoxy-4-propylphenethylamine (2C-P) studied in urine by GC-MS, LC-MS(n), and LC-high-resolution-MS(n).
    Wink CS; Meyer MR; Braun T; Turcant A; Maurer HH
    Anal Bioanal Chem; 2015 Jan; 407(3):831-43. PubMed ID: 25120185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the metabolism and the detectability of 4-methyl-amphetamine and its isomers 2-methyl-amphetamine and 3-methyl-amphetamine in rat urine using GC-MS and LC-(high-resolution)-MSn.
    Welter J; Meyer MR; Kavanagh P; Maurer HH
    Anal Bioanal Chem; 2014 Mar; 406(7):1957-74. PubMed ID: 24452743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.